BDR Pharmaceuticals on Tuesday launched an oral solution in 32mg/mL designed for the management of prostate cancer. According to a press statement, BDENZA will be available at Rs. 27,000 for 150mL. “This innovative formulation marks a significant step forward in providing an effective dosage form, with lesser side effects in comparison to existing oral dosage […]